NMMDX
Price
$9.50
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Net Assets
233.98M
PRVAX
Price
$10.79
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Net Assets
1.29B
Interact to see
Advertisement

NMMDX vs PRVAX

Header iconNMMDX vs PRVAX Comparison
Open Charts NMMDX vs PRVAXBanner chart's image
Nuveen MD Municipal Bond I
Price$9.50
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets233.98M
T. Rowe Price Virginia Tax Free Bond
Price$10.79
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.29B
NMMDX vs PRVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NMMDX vs. PRVAX commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMMDX is a Hold and PRVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRVAX has more cash in the bank: 1.29B vs. NMMDX (234M). NMMDX pays higher dividends than PRVAX: NMMDX (3.77) vs PRVAX (3.07). NMMDX was incepted earlier than PRVAX: NMMDX (34 years) vs PRVAX (34 years). NMMDX (0.63) is less costly to investors than PRVAX (0.55). NMMDX is a more actively managed with annual turnover of: 23.00 vs. PRVAX (19.10). PRVAX has a lower initial minimum investment than NMMDX: PRVAX (2500) vs NMMDX (100000). NMMDX annual gain was more profitable for investors over the last year : -0.74 vs. PRVAX (-1.59). NMMDX return over 5 years is better than : 1.54 vs. PRVAX (-0.34).
NMMDXPRVAXNMMDX / PRVAX
Total Expense Ratio0.560.55102%
Annual Report Gross Expense Ratio0.630.55115%
Fund Existence34 years34 years-
Gain YTD-1.113-1.86660%
Front LoadN/AN/A-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets234M1.29B18%
Annual Yield % from dividends3.773.07123%
Returns for 1 year-0.74-1.5947%
Returns for 3 years7.326.81108%
Returns for 5 years1.54-0.34-457%
Returns for 10 years12.1011.77103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.05N/A
+0.38%
Oncotelic Therapeutics, Inc.
RAIFF32.00N/A
N/A
Raiffeisen Bank International AG
FFXXF1.91N/A
N/A
HELIOS FAIRFAX PARTNERS CORP.
ORPEF14.22N/A
N/A
Orpea ACT
ICNP0.34N/A
N/A
iCoreConnect Inc.